Quantitative pharmacology an introduction to integrative pharmacokinetic-pharmacodynamic analysis

PKPD awareness is vital if we are to attempt to relate preclinical results to the acute and long term consequences in humans. The debate on whether preclinical findings can be translated to the human usage is still engaging scientists across industry, academia and regulatory bodies. Pharmacokinetics...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabrielsson, Johan (Author), Hjorth, Stephan (Author)
Format: Book
Language:English
Published: Stockholm Apotekarsocieteten 2012
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 i 4501
001 wils-516901
005 202187143438
008 210907t2012 SW a# #001 deng
020 # # |a 9789197945233  |q hardback 
020 # # |a 9781466560314  |q hardback 
020 # # |a 1466560312  |q hardback 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QV 38 
090 0 0 |a QV38  |b G1189q 2012 
100 # # |a Gabrielsson, Johan  |e author 
245 1 0 |a Quantitative pharmacology  |b an introduction to integrative pharmacokinetic-pharmacodynamic analysis  |c by Johan Gabrielsson & Stephan Hjorth 
264 # 1 |a Stockholm  |b Apotekarsocieteten  |c 2012 
264 # 4 |c ©2012 
300 # # |a 263 pages  |b illustrations, portraits  |c 24 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a PKPD awareness is vital if we are to attempt to relate preclinical results to the acute and long term consequences in humans. The debate on whether preclinical findings can be translated to the human usage is still engaging scientists across industry, academia and regulatory bodies. Pharmacokinetics (PK) and pharmacodynamics (PD) comprise traditionally distinct disciplines within pharmacology, the study of the interaction of drugs with the body. It is our intention to show that by deliberately, intimately and systematically integrate these disciplines our understanding of drugs and the efficiency and effectiveness of drug discovery and development may be greatly enhanced. The book is therefore written with a broad audience in mind and focuses on concepts. Pharmacologists of all sorts, safety scientists, pharmacokineticists, medicinal chemists, clinicians, statisticians, veterinarians, animal science professionals, project leaders and students of medical, pharmaceutical and veterinary sciences are the primary targets. This textbook Introduces the basics of PK and PD concepts Outlines the implications of integrating PK and PD analysis Introduces the principles behind different biomarkers and inter-species scaling Discusses experimental design of PK, PD and safety studies in non-human species Covers numerous real life Case Studies from the drug discovery arena 
650 1 2 |a Pharmacokinetics 
650 2 2 |a Pharmacological Phenomena 
650 2 2 |a Models, Statistical 
700 1 # |a Hjorth, Stephan  |e author 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=516901 
998 # # |a 00100##a006.2.2||00100##b0011.2.2||00100##c006.2.2||00100##d006.2.2||00100##q006.2.2||00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2||